Skip to content
Home/Companies/Biotech/Isarna Therapeutics
Isarna Therapeutics

Isarna Therapeutics

Biotech·Germany·Active·21yr hold
Entry
2005
Hold
21yr
Status
Active

Who owns Isarna Therapeutics?

Isarna Therapeutics is currently owned by MIG Capital through MIG Fonds 5 (2007 vintage), since 2005.

Hand-verified · updated 2026-07-03

MIG Capital
Investor
MIG Capital
MIG Fonds 5 · 2007 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive
Websiteisarna-therapeutics.com

More from MIG Fonds 5

Other portfolio companies in the same fund.

advanceCOR
Active
BiotechGermany· 2012
Immatics
Immatics
Exited 2020
BiotechGermany· 2010
AmSilk
Active
BiotechGermany· 2008
instrAction
instrAction
Active
Deep TechGermany· 2008
OD-OS
Od-os
Active
MedTechGermany· 2008
Ganymed Pharmaceuticals
Exited 2016
BiotechGermany· 2007
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Isarna Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Isarna Therapeutics?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Isarna Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue